Optimum Management of Hemodialysis Patient
Sohair Sabry Saad;
Abstract
Optimal management of iron deficiency anaemia leads to a substantial
reduction in epoetin dosage (20–70%). Pentoxifylline administration will safely
and effectively treat erythropoietin-alpha or darbepoietin-alpha resistant
anaemia. Continuous Erythrop
reduction in epoetin dosage (20–70%). Pentoxifylline administration will safely
and effectively treat erythropoietin-alpha or darbepoietin-alpha resistant
anaemia. Continuous Erythrop
Other data
| Title | Optimum Management of Hemodialysis Patient | Other Titles | الاهتمام بدرجة مثاليه بمريض الديلزه الدموية | Authors | Sohair Sabry Saad | Keywords | Optimum Management of Hemodialysis Patient | Issue Date | 2010 | Description | Optimal management of iron deficiency anaemia leads to a substantial reduction in epoetin dosage (20–70%). Pentoxifylline administration will safely and effectively treat erythropoietin-alpha or darbepoietin-alpha resistant anaemia. Continuous Erythrop |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 91088Binder1.pdf | 179.89 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.